Varonis Systems Inc (FRA:VS2)
€ 53.1 1.2 (2.31%) Market Cap: 5.96 Bil Enterprise Value: 5.66 Bil PE Ratio: 0 PB Ratio: 14.04 GF Score: 72/100

Q1 2024 Varonis Systems Inc Earnings Call Transcript

May 06, 2024 / 08:30PM GMT
Release Date Price: €40.56 (-1.65%)

Key Points

Positve
  • Varonis Systems Inc (VRNS) reported a 17% year-over-year growth in Annual Recurring Revenue (ARR) to $560.3 million.
  • The company generated $56.4 million in free cash flow this quarter, up from $35.7 million in the same period last year.
  • SaaS ARR now represents approximately 70% of total ARR, indicating strong adoption of the SaaS model.
  • The introduction of Managed Data Detection and Response (MDDR) service has been well received, contributing positively to new business and deal sizes.
  • Varonis Systems Inc (VRNS) is advancing its partnership with Microsoft, including a cybersecurity solution for Microsoft 365 Copilot, enhancing platform appeal and potential market reach.
Negative
  • Despite the growth in ARR and free cash flow, Varonis Systems Inc (VRNS) reported a net loss of $3.7 million for the quarter.
  • The transition to a SaaS model, while beneficial in the long term, is creating short-term revenue headwinds due to ratable revenue recognition.
  • Operating expenses for the quarter totaled $105.6 million, leading to an operating loss of $10.6 million.
  • The company faces increased competition in the security sector, particularly as other companies enhance their data security offerings.
  • While the company is seeing interest in its new GenAI and MDDR initiatives, these are still in early stages and have not yet significantly impacted financial results.
Operator

Greetings, and welcome to bet on this system Inc. First Quarter 2024 earnings conference call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone key pad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Tim plus Investor Relations. Thank you, Mr. Bosch, you may begin.

Tim Perz
Varonis Systems Inc - Director - Investor Relations

Thank you, operator. Good afternoon, and thank you for joining us today to review Verona Pharma's First Quarter Financial Results. The on the call today are Yaki Faitelson, Chief Executive Officer, Guy Melamed, Chief Financial Officer and Chief Operating Officer of Heritage. After preliminary remarks, we will open the call to a question and answer session.

During this call, we may make statements related to our business that would be considered forward-looking statements under federal

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot